Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Antiangiogenic compounds: well-established drugs versus emerging natural molecules
Publication

Publications

Antiangiogenic compounds: well-established drugs versus emerging natural molecules

Title
Antiangiogenic compounds: well-established drugs versus emerging natural molecules
Type
Article in International Scientific Journal
Year
2018
Authors
Andreia Ribeiro
(Author)
FEUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Rui M. V. Abreu
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Maria Filomena Barreiro
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Isabel C. F. R. Ferreira
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Title: Cancer LettersImported from Authenticus Search for Journal Publications
Vol. 415
Pages: 86-105
ISSN: 0304-3835
Publisher: Elsevier
Other information
Authenticus ID: P-00N-KMX
Abstract (EN): Angiogenesis is the natural and physiologic process of growing blood vessels from pre-existing ones. Pathological angiogenesis occurs when the precise balance of all the molecular pathways that regulate angiogenesis is disrupted, and this process is a critical step in many diseases, including cancer. A limited number of antiangiogenic synthetic drugs have been developed. However, due to toxicity and side effects issues, the search for alternative to existing drugs is ongoing. In this sense, natural molecules obtained from plants or macrofungi, have demonstrated extraordinary potential in the treatment of angiogenesis-related pathologies, specially taking into consideration its absence or very low toxicity, when compared to synthetic drugs. Using natural compounds as potential angiogenesis modulators is thus a promising field of research, supporting the creation of novel therapies able to reduce the use of drugs and associated side effects. In this review, the current status of antiangiogenic drugs and the wide variety of natural extracts and molecules with antiangiogenic capacities, as well as the angiogenesis molecular pathways and therapeutic targets, are presented. Finally, the challenges that need to be overcome in order to increase the use of natural compounds for clinical purposes are discussed.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 20
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Thyroid hormone as a regulator of tumor induced angiogenesis (2011)
Another Publication in an International Scientific Journal
Marta Pinto; Paula Soares; Domenico Ribatti
Reply to: Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas (2005)
Another Publication in an International Scientific Journal
Lima, J; Trovisco, V; Soares, P; Maximo, V; Magalhaes, J; Salvatore, G; Santoro, M; Bogdanova, T; Tronko, M; Abrosimov, A; Jeremiah, S; Thomas, G; Williams, D; Sobrinho Simoes, M
Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics (2017)
Another Publication in an International Scientific Journal
Ferreira, JA; Magalhaes, A; Gomes, J; Peixoto, A; Gaiteiro, C; Fernandes, E; Santos, LL; Celso Reis
Suppression of spindly delays mitotic exit and exacerbates cell death response of cancer cells treated with low doses of paclitaxel (2017)
Article in International Scientific Journal
Silva, PMA; Ribeiro, N; Lima, RT; Andrade, C; Diogo, V; Teixeira, J; Florindo, C; Tavares, A; Helena Vasconcelos, MH; Bousbaa, H
Role of site-specific promoter hypomethylation in aberrant MUC2 mucin expression in mucinous gastric carcinomas (2003)
Article in International Scientific Journal
Mesquita, P; Peixoto, AJ; Seruca, R; Hanski, C; Raquel Almeida; Santos-Silva F; Celso Reis; David L

See all (16)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-06 at 05:52:14 | Privacy Policy | Personal Data Protection Policy | Whistleblowing